Skip to main content
. Author manuscript; available in PMC: 2023 Jun 15.
Published in final edited form as: Clin Cancer Res. 2022 Dec 15;28(24):5405–5418. doi: 10.1158/1078-0432.CCR-22-0963

Fig. 2. HIF2α silencing and VEGF downregulation by siHIF2.

Fig. 2.

A. Representative immunohistochemistry images illustrating HIF2α protein depletion by A1HIF2 in TGs. B. Western blot analyses of HIF2α in A1HIF2 treated TG-bearing mice. C. Human VEGF ELISA of circulating tumor-produced VEGF in A1HIF2 or vehicle treated mice. *, p < 0.05. Error bars represent standard deviation.